Shares of Amarin (AMRN -20.5%) are getting hammered this morning on the back of yesterday's announcement that it was raising funds and will begin hiring a sales force to independently launch Vascepa. The news disappointed investors who had hoped the biotech would have a partner by now. The company has already undertaken extensive preparations to launch the drug, but had held off on the costly move of hiring its own sales staff.
Are you Bullish or Bearish on ?
Sentiment on ()
Thanks for sharing your thoughts.